Bio-Rad Sees Improved Research Spending Fourth quarter 2015 sales for Bio-Rad Laboratories Life Science (LS) contracted 2.5% to $218.1 million to account for 38% of revenues. However, excluding currency, organic sales advanced 3.4%, led by demand for digital PCR, process media, cell biology and western blotting products. Geographically, organic growth was strongest in China, Europe […]
Companies continue to sharpen their focus on integrated solutions and workflows to increase lab productivity and differentiate themselves in the marketplace. At this year’s Pittcon, IBO spoke with executives at MilliporeSigma, Shimadzu Scientific Instruments (SSI) and Thermo Fisher Scientific. Each company has recently reorganized executive responsibilities to reflect an emphasis on the integration of workflow […]
After a five-year absence from Atlanta, Georgia, Pittcon returned to the city this year from March 6 to March 10. Attendance figures as of the end of the day on March 9 showed that conferee attendance declined 14.9% to 6,890. Exhibitor attendance was down 12.6% to 5,064. With Europe’s largest analytical instrument show, Analytica, taking […]
Agilent Posts Solid Quarter Agilent Technologies fiscal first quarter revenues ending January 31 improved 0.2%, 6.4% organically, to $1.03 billion (see page 12). Sales were slightly ahead of company expectations, driven by strength in the pharmaceutical, and clinical and diagnostics markets. Furthermore, academic and government sales returned to growth due to increased government spending in […]
The annual Association of Biomolecular Resource Facilities (ABRF) conference was held in Ft. Lauderdale, Florida, this year. Conference attendance increased for the third year in a row and included 559 attendees and 237 exhibitors. ABRF 2017 will be held in San Diego, California. Over three days, the 45 conference presentations and workshops addressed five topic […]
In February, the S&P 500 and NASDAQ declined for the third consecutive month, sliding 0.4% and 1.2%, respectively. Meanwhile, the Dow Jones Industrial Average weathered the negative trend as it posted a modest gain of 0.3%. Equity markets were extremely volatile as a result of fluctuating oil prices and anxieties over global economic growth. Nevertheless, […]
CRISPR is a disruptive gene editing methodology that has invigorated the genomics market, taking life science research to another level of innovation. With explosive growth, the technology is not only creating opportunities in genetic engineering but is fueling growth for enabling technologies, such as NGS, PCR, lab automation, microarrays, nucleic acid preparation kits, flow cytometry […]
A majority of large publicly held instrument and lab product companies ended 2015 on a strong note, benefiting from sustained demand from biopharmaceutical customers and steady growth in applied markets. Nevertheless, currency effects along with weak industrial markets continued to dampen organic top line growth. Moreover, several companies were negatively impacted by fewer selling days […]
The eighth annual Association for Mass Spectrometry: Applications to the Clinical Laboratory conference (MSACL) was held in Palm Springs, California, from February 21 to February 25, its first year outside of San Diego, California. Selected presentations on Thursday evidenced both optimism about MS’s future in clinical diagnostics and the need for greater progress. The conference […]
Illumina Fueled by Clinical Adoption Illumina’s fourth quarter 2015 sales grew 15.5%, 19% excluding currency, to $591.5 million. Excluding currency, Product revenue grew roughly 15%, and Service and Other revenue jumped 55% to account for 84% and 16% of revenues, respectively. Sequencing sales grew 19%, 23% excluding currency, driven by continued adoption in clinical oncology […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
